The purpose of the Histopathology Facility is two-fold: to process research animal tissues for conventional and specialized histology, and to provide histopathological evaluation of the tissues through a team of trained pathologists. The Facility occupies about 630 sq., feet of floor surface, and is physically located in the Unit 3 of the NDI, within the Division of Pathology and Toxicology. Currently, the Facility is staffed with three pathologists and three histologists. From the six, only 1.75 are AHFCC supported. The Facilities organizations and functions are very similar to those of any histology laboratory in non-clinical laboratories, hospitals or medical research institutions, having all standard equipment for conventional and specialized histopathology. The major pieces of equipment include 2 tissue processors, an embedding center, 2 rotary microtomes, a cryostat, 3 microscopes and one Videoplan image analyzer. The equipment is in good or excellent working condition. As such the Facility is capable of processing tissues and preparing slides from intramural and extramural experimental laboratory animal studies and human specimens. Furthermore, the Facility is in compliance with non-clinical good laboratory practice (GLP) rules. The ability of the Facility to perform various established techniques, to adapt and refine existing methodology, and to develop new analytic procedures is of vital importance in correlating molecular events to cellular responses. Consequently, a diverse group of AHFCC investigators rely on histopathology to provide fundamental biological and histopathological data from a wide range of experimental objectives. During the last 5 year period, 61 papers, all originating from CCSG-supported programs, have been co-authored by pathologists and have been published in peer-reviewed journals. Among special immunohistochemical techniques used are BrdU,PCNA,Ki67,p53,GST- P,GS,COX1,COX2, VEGF, ER, PR, TUNEL, ISEL, intermediate filaments and cytoskeletal protein procedures. In general, any special known technique can be performed. The Facility operates on a partial cost-recovery system with investigators being charged on a per slide basis for all work. Per slide costs include diagnostic evaluation by a pathologist. A listing of the investigators who use the Facility in 1996-1997 is given below. The Histopathology Facility to date has made fundamental contributions to the research objectives of the AHFCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA017613-24
Application #
6101847
Study Section
Project Start
1998-12-18
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
24
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Institute for Cancer Prevention
Department
Type
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Rennert, Gad; Kremer, Ran; Rennert, Hedy S et al. (2015) Lower lung cancer rates in Jewish smokers in Israel and the USA. Int J Cancer 137:2155-62
Beyea, Jan; Stellman, Steven D; Teitelbaum, Susan et al. (2013) Imputation method for lifetime exposure assessment in air pollution epidemiologic studies. Environ Health 12:62
Boffetta, Paolo; Jayaprakash, Vijayvel; Yang, Ping et al. (2011) Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control 22:73-9
Farooq, Umar; Joshi, Monika; Nookala, Vinod et al. (2010) Self-reported exposure to pesticides in residential settings and risk of breast cancer: a case-control study. Environ Health 9:30
Muscat, Joshua E; Stellman, Steven D; Caraballo, Ralph S et al. (2009) Time to first cigarette after waking predicts cotinine levels. Cancer Epidemiol Biomarkers Prev 18:3415-20
Stellman, Steven D; Djordjevic, Mirjana V (2009) Monitoring the tobacco use epidemic II: The agent: Current and emerging tobacco products. Prev Med 48:S11-5
Watanabe, Karen H; Djordjevic, Mirjana V; Stellman, Steven D et al. (2009) Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data. Regul Toxicol Pharmacol 55:123-33
Stellman, Steven D (2006) Ernst Wynder: a remembrance. Prev Med 43:239-45
El-Bayoumy, Karam; Sinha, Raghu (2004) Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 551:181-97
Boyiri, Telih; Guttenplan, Joseph; Khmelnitsky, Michael et al. (2004) Mammary carcinogenesis and molecular analysis of in vivo cII gene mutations in the mammary tissue of female transgenic rats treated with the environmental pollutant 6-nitrochrysene. Carcinogenesis 25:637-43

Showing the most recent 10 out of 27 publications